Research teams that develop the most effective clinical protocol for the use of CT scans in fighting COVID-19 will be awarded prizes from the USD 1.8m purse.
The new COVID-19 CT Scan Collaborative includes Mount Sinai Hospital, the Open-QIC COVID Registry and the endcoronavirus.org network.
XPRIZE is in designing and operating incentive competitions to solve humanity's grand challenges, and it recently announced a global XPRIZE Pandemic Alliance, which launched two major international competitions to address the COVID-19 pandemic: the XPRIZE NextGen Mask Challenge and XPRIZE Rapid COVID Testing.
The COVID-19 CT Scan Collaborative will operate the prize, and the XPRIZE Pandemic Alliance will help develop best practices and convene teams for the competition.
CT scans with high detection capabilities have the potential to increase testing access, disease monitoring and identification of early and asymptomatic cases.
As new radiology protocols typically take years to develop, this unprecedented, real-time collaboration will enable radiologists worldwide to view anonymized CT scans to improve their results.
The goal of the COVID-19 CT Scan Collaborative is to exponentially advance the development of CT scan clinical protocols for management of COVID-19 infections and increase the availability, ease and accuracy of diagnoses.
XPRIZE, a 501(c) (3) nonprofit, is a leader in designing and implementing innovative competition models to solve the world's grandest challenges.
The XPRIZE Pandemic Alliance is a global coalition that combines the power of collaboration, competition, innovation and radical thinking to accelerate solutions that can be applied to COVID-19 and future pandemics.
The New England Complex Systems Institute (NECSI) is an independent academic research and educational institution with students, postdoctoral fellows and faculty. In addition to the in-house research team, NECSI has co-faculty, students and affiliates from MIT, Harvard, Brandeis and other leading institutions.
EndCoronavirus is an international volunteer coalition of over 15,000 scientists and experts who develop and promote community-based solutions for policy makers, businesses and individuals. It was founded by The New England Complex Systems Institute in February 2020.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA